03067nam 2200625 a 450 991081485360332120240417005910.00-309-21932-91-283-31196-897866133119620-309-21930-2(CKB)2550000000058076(OCoLC)769188485(CaPaEBR)ebrary10506513(SSID)ssj0000630697(PQKBManifestationID)11390391(PQKBTitleCode)TC0000630697(PQKBWorkID)10747025(PQKB)11528330(MiAaPQ)EBC3378890(Au-PeEL)EBL3378890(CaPaEBR)ebr10506513(CaONFJC)MIL331196(OCoLC)923284553(EXLCZ)99255000000005807620121114d2011 uy 0engurcn|||||||||txtccrPublic engagement and clinical trials new models and disruptive technologies : workshop summary /Victoria Weisfeld, Rebecca A. English, and Anne B. Clairborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation Board on Health Sciences Policy, Institute of Medicine of the National Academies1st ed.Washington, D.C. National Academies Press20111 online resource (115 p.)Bibliographic Level Mode of Issuance: Monograph0-309-21929-9 Includes bibliographical references.Introduction -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public engagement -- Messages and methods for public engagement -- The media -- Novel clinical trials designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials.Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials.Clinical trialsClinical trials.610.72/4Weisfeld Victoria1602350English Rebecca A1602351Claiborne Anne B1601264Institute of Medicine (U.S.)Public Engagement and Clinical Trials: New Models and Disruptive TechnologiesMiAaPQMiAaPQMiAaPQBOOK9910814853603321Public engagement and clinical trials3926301UNINA